In Down syndrome patients, partially mitigating the overactivity of the Dyrk1a gene in mice reversed the defects laying the groundwork for potential future therapies.from Medindia Health News https://ift.tt/r0ZvFdo
via
 In Down syndrome patients, partially mitigating the overactivity of the Dyrk1a gene in mice reversed the defects laying the groundwork for potential future therapies.
About Unknown
No comments:
Post a Comment